Gestational trophoblastic disease (GTD)
Open
Phase 2
This study is looking at the immunotherapy drug pembrolizumab before surgery for that has not spread.
It is for people who:
have had surgery to try and remove a but it hasn’t completely gone and
have now developed a type of gestational trophoblastic tumour which is cancer and
are going to have surgery again to try and remove the cancer
Recruitment start: 14 February 2024
Recruitment end: 31 August 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ehsan Ghorani
Cancer Research UK
Cancer Research UK Imperial Centre: Clinical Trials Section
Imperial College London
NIHR Imperial Biomedical Research Centre
Last reviewed: 30 Jan 2025
CRUK internal database number: 18763